Dr. David Farrell, clinical professor of surgery at OHSU and founder and Chief Scientific Officer at Gamma Diagnostics Inc., shares his poster and abstract at the American Heart Association meeting. COVID-19 patients can develop extremely high levels of gamma prime fibrinogen (GPF) which has several important clinical implications relative to administration of anticoagulants and steroids. Click here to read more.
Search
Recent Posts
See AllGamma Diagnostics Inc. (GDx) and Oregon Health & Science University (OHSU) have signed a licensing agreement that seeks to further develop and commercially promote the use of Gamma Prime Fibrinoge
50
Stay tuned for an exciting Covid-19 study and a newly identified thrombosis biomarker to be presented at the American Heart Association meeting on Nov 13th by our founder, Dr. David Farrell, Professo
370
We are happy to announce Gamma Diagnostics joined Expert DOJO's September 2021 #healthcare accelerator program. With their healthcare industry expertise, they are giving 110% to transform the healthc
36